2024 Q2 Form 10-Q Financial Statement

#000140549524000072 Filed on May 02, 2024

View on sec.gov

Income Statement

Concept 2024 Q2 2024 Q1 2023 Q1
Revenue $223.5M $263.5M $202.4M
YoY Change 119.99% 30.23% 99.74%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $39.44M $110.4M $33.68M
YoY Change 39.19% 227.85% 209.47%
% of Gross Profit
Research & Development $50.15M $49.38M $49.43M
YoY Change 0.54% -0.11% 180.66%
% of Gross Profit
Depreciation & Amortization $17.38M $17.24M $19.53M
YoY Change -11.55% -11.71% 1.27%
% of Gross Profit
Operating Expenses $89.59M $159.8M $83.11M
YoY Change 14.54% 92.28% 191.66%
Operating Profit $133.9M $103.7M $119.3M
YoY Change 472.84% -13.02% 295.1%
Interest Expense -$1.358M $11.92M $12.09M
YoY Change -111.19% -1.37% 119.17%
% of Operating Profit -1.01% 11.49% 10.13%
Other Income/Expense, Net $11.68M $9.247M $13.19M
YoY Change -18.8% -29.9% -1186.57%
Pretax Income $134.1M $101.1M $120.4M
YoY Change 423.4% -16.04% 408.62%
Income Tax $24.44M $19.41M $16.85M
% Of Pretax Income 18.23% 19.21% 13.99%
Net Earnings $109.7M $81.65M $105.3M
YoY Change 403.44% -22.43% 484.97%
Net Earnings / Revenue 49.07% 30.98% 52.01%
Basic Earnings Per Share $4.35 $3.20 $3.66
Diluted Earnings Per Share $3.93 $2.88 $3.58
COMMON SHARES
Basic Shares Outstanding 25.24M shares 25.49M shares 29.67M shares
Diluted Shares Outstanding 27.91M shares 28.34M shares 29.37M shares

Balance Sheet

Concept 2024 Q2 2024 Q1 2023 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $760.3M $984.6M $950.7M
YoY Change -9.56% 3.57% 5.72%
Cash & Equivalents $299.8M $440.2M $430.6M
Short-Term Investments $460.6M $544.4M $520.1M
Other Short-Term Assets $6.591M $9.473M $7.806M
YoY Change -40.99% 21.36% 66.55%
Inventory
Prepaid Expenses $35.78M $32.79M $13.45M
Receivables $223.6M $145.6M $144.0M
Other Receivables $21.54M $0.00 $66.85M
Total Short-Term Assets $1.057B $1.215B $1.196B
YoY Change -11.33% 1.59% 19.5%
LONG-TERM ASSETS
Property, Plant & Equipment $10.86M $11.08M $11.45M
YoY Change -7.04% -3.15% -7.06%
Goodwill $22.42M $22.42M $22.42M
YoY Change 0.0% 0.0% 0.0%
Intangibles
YoY Change
Long-Term Investments $35.15M $33.48M $19.72M
YoY Change 79.51% 69.83% -7.35%
Other Assets $165.9M $156.1M $114.7M
YoY Change 32.65% 36.0% 10.11%
Total Long-Term Assets $579.2M $591.6M $552.1M
YoY Change 1.96% 7.14% -7.17%
TOTAL ASSETS
Total Short-Term Assets $1.057B $1.215B $1.196B
Total Long-Term Assets $579.2M $591.6M $552.1M
Total Assets $1.636B $1.807B $1.749B
YoY Change -7.04% 3.34% 9.56%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $8.091M $168.5M $8.464M
YoY Change -2.67% 1890.6% 40.76%
Accrued Expenses $40.89M $122.2M $57.66M
YoY Change -62.25% 111.86% 8.45%
Deferred Revenue $156.8M $156.0M $178.8M
YoY Change -9.19% -12.78% -25.06%
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $453.8M $579.4M
YoY Change 261.2%
Total Short-Term Liabilities $699.3M $903.8M $254.4M
YoY Change 56.63% 255.28% -17.57%
LONG-TERM LIABILITIES
Long-Term Debt $17.69M $28.03M $607.9M
YoY Change -96.35% -95.39% 43.34%
Other Long-Term Liabilities $56.22M $56.93M $55.89M
YoY Change -1.05% 1.85% 10.07%
Total Long-Term Liabilities $73.91M $84.96M $663.8M
YoY Change -86.33% -87.2% 39.78%
TOTAL LIABILITIES
Total Short-Term Liabilities $699.3M $903.8M $254.4M
Total Long-Term Liabilities $73.91M $84.96M $663.8M
Total Liabilities $939.5M $1.183B $1.123B
YoY Change -18.99% 5.29% 34.46%
SHAREHOLDERS EQUITY
Retained Earnings $1.632B $1.533B $1.384B
YoY Change 16.9% 10.76% -4.41%
Common Stock $699.0K $696.0K $693.0K
YoY Change 0.87% 0.43% -3.48%
Preferred Stock
YoY Change
Treasury Stock (at cost) $1.484B
YoY Change 5.28%
Treasury Stock Shares
Shareholders Equity $696.8M $624.3M $619.7M
YoY Change
Total Liabilities & Shareholders Equity $1.636B $1.807B $1.749B
YoY Change -7.04% 3.34% 9.56%

Cashflow Statement

Concept 2024 Q2 2024 Q1 2023 Q1
OPERATING ACTIVITIES
Net Income $109.7M $81.65M $105.3M
YoY Change 403.44% -22.43% 484.97%
Depreciation, Depletion And Amortization $17.38M $17.24M $19.53M
YoY Change -11.55% -11.71% 1.27%
Cash From Operating Activities -$48.91M $50.77M -$27.85M
YoY Change 7.64% -282.3% 54.97%
INVESTING ACTIVITIES
Capital Expenditures $13.18M $444.0K $1.209M
YoY Change 1.11% -63.28% 258.75%
Acquisitions
YoY Change
Other Investing Activities $93.90M $26.19M -$5.982M
YoY Change -334.49% -537.85% -105.08%
Cash From Investing Activities $80.72M $16.78M -$14.46M
YoY Change -252.07% -215.99% -113.44%
FINANCING ACTIVITIES
Cash Dividend Paid $10.23M $10.38M
YoY Change -1.52% -3.32%
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net $1.590M $0.00
YoY Change
Cash From Financing Activities -184.0M -$49.32M -$218.1M
YoY Change 245.13% -77.39% 1572.69%
NET CHANGE
Cash From Operating Activities -48.91M $50.77M -$27.85M
Cash From Investing Activities 80.72M $16.78M -$14.46M
Cash From Financing Activities -184.0M -$49.32M -$218.1M
Net Change In Cash -152.2M $18.23M -$260.5M
YoY Change 0.24% -107.0% -440.06%
FREE CASH FLOW
Cash From Operating Activities -$48.91M $50.77M -$27.85M
Capital Expenditures $13.18M $444.0K $1.209M
Free Cash Flow -$62.09M $50.33M -$29.06M
YoY Change 6.18% -273.18% 58.73%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2023Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2023Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-1739000 usd
CY2024Q1 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P9M
CY2024Q1 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P1Y
CY2024Q1 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P1Y
CY2024Q1 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P1Y
CY2024Q1 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P1Y
CY2024Q1 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
CY2024Q1 idcc Research And Portfolio Development Expense
ResearchAndPortfolioDevelopmentExpense
49375000 usd
CY2023Q1 idcc Research And Portfolio Development Expense
ResearchAndPortfolioDevelopmentExpense
49429000 usd
CY2024Q1 idcc Licensing Costs
LicensingCosts
96589000 usd
CY2023Q1 idcc Licensing Costs
LicensingCosts
21368000 usd
CY2024Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
13840000 usd
CY2023Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
12315000 usd
CY2024Q1 us-gaap Costs And Expenses
CostsAndExpenses
159804000 usd
CY2023Q1 us-gaap Costs And Expenses
CostsAndExpenses
83112000 usd
CY2024Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
103738000 usd
CY2023Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
119261000 usd
CY2024Q1 us-gaap Interest Expense
InterestExpense
11922000 usd
CY2024Q1 us-gaap Profit Loss
ProfitLoss
81652000 usd
CY2023Q1 us-gaap Profit Loss
ProfitLoss
103520000 usd
CY2024Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
17240000 usd
CY2023Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
19526000 usd
CY2023Q1 us-gaap Interest Expense
InterestExpense
12087000 usd
CY2024Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
9247000 usd
CY2023Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
13191000 usd
CY2024Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
101063000 usd
CY2023Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
120365000 usd
CY2024Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
19411000 usd
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
16845000 usd
CY2024Q1 us-gaap Profit Loss
ProfitLoss
81652000 usd
CY2023Q1 us-gaap Profit Loss
ProfitLoss
103520000 usd
CY2024Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
0 usd
CY2023Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-1739000 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
81652000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
105259000 usd
CY2024Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
3.20
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
3.66
CY2024Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
25510000 shares
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
28780000 shares
CY2024Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
2.88
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
3.58
CY2024Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
28341000 shares
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
29372000 shares
CY2024Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.40
CY2023Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.35
CY2024Q1 us-gaap Profit Loss
ProfitLoss
81652000 usd
CY2023Q1 us-gaap Profit Loss
ProfitLoss
103520000 usd
CY2024Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-495000 usd
CY2023Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
579000 usd
CY2024Q1 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
81157000 usd
CY2023Q1 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
104099000 usd
CY2024Q1 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
0 usd
CY2023Q1 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
-1739000 usd
CY2024Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
81157000 usd
CY2023Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
105838000 usd
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
730513000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
105259000 usd
CY2023Q1 us-gaap Noncontrolling Interest Increase From Subsidiary Equity Issuance
NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance
1750000 usd
CY2023Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
579000 usd
CY2023Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.35
CY2023Q1 us-gaap Dividends
Dividends
9449000 usd
CY2023Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
687000 usd
CY2023Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
-6708000 usd
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
7790000 usd
CY2023Q1 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
203381000 usd
CY2023Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
625301000 usd
CY2023Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
581549000 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
81652000 usd
CY2024Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-495000 usd
CY2024Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.40
CY2024Q1 us-gaap Dividends
Dividends
10147000 usd
CY2024Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
-8635000 usd
CY2024Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
9386000 usd
CY2024Q1 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
29019000 usd
CY2024Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
624291000 usd
CY2024Q1 idcc Non Cash Interest Income Expense Net
NonCashInterestIncomeExpenseNet
-3661000 usd
CY2023Q1 idcc Non Cash Interest Income Expense Net
NonCashInterestIncomeExpenseNet
-3434000 usd
CY2024Q1 idcc Non Cash Change In Investments
NonCashChangeInInvestments
1247000 usd
CY2023Q1 idcc Non Cash Change In Investments
NonCashChangeInInvestments
-158000 usd
CY2024Q1 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-27542000 usd
CY2023Q1 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-42766000 usd
CY2024Q1 us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
-11789000 usd
CY2023Q1 us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
-12471000 usd
CY2024Q1 us-gaap Share Based Compensation
ShareBasedCompensation
9386000 usd
CY2023Q1 us-gaap Share Based Compensation
ShareBasedCompensation
7790000 usd
CY2024Q1 us-gaap Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
0 usd
CY2023Q1 us-gaap Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
2567000 usd
CY2024Q1 us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
28337000 usd
CY2023Q1 us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
90856000 usd
CY2024Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
27577000 usd
CY2023Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
31091000 usd
CY2024Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
3522000 usd
CY2023Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-2807000 usd
CY2024Q1 us-gaap Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
13054000 usd
CY2023Q1 us-gaap Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
-2614000 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
50773000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-27852000 usd
CY2024Q1 us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
167086000 usd
CY2023Q1 us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
309393000 usd
CY2024Q1 us-gaap Proceeds From Sale Of Short Term Investments
ProceedsFromSaleOfShortTermInvestments
191702000 usd
CY2023Q1 us-gaap Proceeds From Sale Of Short Term Investments
ProceedsFromSaleOfShortTermInvestments
303411000 usd
CY2024Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
444000 usd
CY2023Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1209000 usd
CY2024Q1 idcc Capitalized Patent Costs
CapitalizedPatentCosts
8973000 usd
CY2023Q1 idcc Capitalized Patent Costs
CapitalizedPatentCosts
7272000 usd
CY2024Q1 us-gaap Payments For Proceeds From Longterm Investments
PaymentsForProceedsFromLongtermInvestments
-1576000 usd
CY2023Q1 us-gaap Payments For Proceeds From Longterm Investments
PaymentsForProceedsFromLongtermInvestments
0 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
16775000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-14463000 usd
CY2024Q1 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
1590000 usd
CY2023Q1 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
0 usd
CY2024Q1 us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
0 usd
CY2023Q1 us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
100000 usd
CY2024Q1 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
28868000 usd
CY2023Q1 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
203381000 usd
CY2024Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
0 usd
CY2023Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
687000 usd
CY2024Q1 us-gaap Proceeds From Minority Shareholders
ProceedsFromMinorityShareholders
0 usd
CY2023Q1 us-gaap Proceeds From Minority Shareholders
ProceedsFromMinorityShareholders
1750000 usd
CY2024Q1 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
8635000 usd
CY2023Q1 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
6708000 usd
CY2024Q1 us-gaap Payments Of Dividends
PaymentsOfDividends
10226000 usd
CY2023Q1 us-gaap Payments Of Dividends
PaymentsOfDividends
10384000 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-49319000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-218136000 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
18229000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-260451000 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
442961000 usd
CY2024Q1 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
120400000 usd
CY2023Q4 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
94600000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
703161000 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
461190000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
442710000 usd
CY2024Q1 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
1 segment
CY2024Q1 us-gaap Use Of Estimates
UseOfEstimates
<div style="margin-bottom:9pt;margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities as of the date of the financial statements, as well as the reported amounts of revenues and expenses during the reporting period. Actual results could differ from these estimates.</span></div>
CY2024Q1 us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<div style="margin-bottom:6pt;margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain reclassifications have been made to prior year amounts to conform to the current year presentation.</span></div>
CY2024Q1 us-gaap Income Taxes Paid
IncomeTaxesPaid
9335000 usd
CY2023Q1 us-gaap Income Taxes Paid
IncomeTaxesPaid
4942000 usd
CY2024Q1 us-gaap Dividends Payable Current
DividendsPayableCurrent
10155000 usd
CY2023Q1 us-gaap Dividends Payable Current
DividendsPayableCurrent
9449000 usd
CY2024Q1 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
2189000 usd
CY2023Q1 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
0 usd
CY2024Q1 idcc Increase Decrease In Capital And Intangible Asset Expenditures Incurred But Not Yet Paid
IncreaseDecreaseInCapitalAndIntangibleAssetExpendituresIncurredButNotYetPaid
-1358000 usd
CY2023Q1 idcc Increase Decrease In Capital And Intangible Asset Expenditures Incurred But Not Yet Paid
IncreaseDecreaseInCapitalAndIntangibleAssetExpendituresIncurredButNotYetPaid
-1274000 usd
CY2024Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
263542000 usd
CY2023Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
202373000 usd
CY2024Q1 idcc Increase Decrease In Disaggregated Revenue
IncreaseDecreaseInDisaggregatedRevenue
61169000 usd
CY2024Q1 idcc Percentage Increase Decrease In Disaggregated Revenue
PercentageIncreaseDecreaseInDisaggregatedRevenue
0.30
CY2024Q1 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
49900000 usd
CY2024Q1 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
252057000 usd
CY2024Q1 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
323620000 usd
CY2024Q1 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
230456000 usd
CY2024Q1 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
227858000 usd
CY2024Q1 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
215821000 usd
CY2024Q1 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
265882000 usd
CY2024Q1 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
1515694000 usd
CY2024Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
440242000 usd
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
437076000 usd
CY2023Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
430625000 usd
CY2024Q1 us-gaap Restricted Cash Current
RestrictedCashCurrent
20948000 usd
CY2023Q4 us-gaap Restricted Cash Current
RestrictedCashCurrent
5885000 usd
CY2023Q1 us-gaap Restricted Cash Current
RestrictedCashCurrent
12085000 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
461190000 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
442961000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
442710000 usd
CY2024Q1 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
1005583000 usd
CY2023Q4 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
1012241000 usd
CY2024Q1 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
32792000 usd
CY2023Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
9353000 usd
CY2024Q1 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
21959000 usd
CY2023Q4 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
19835000 usd
CY2024Q1 us-gaap Restricted Cash Current
RestrictedCashCurrent
20948000 usd
CY2023Q4 us-gaap Restricted Cash Current
RestrictedCashCurrent
5885000 usd
CY2024Q1 us-gaap Other Assets Current
OtherAssetsCurrent
9473000 usd
CY2023Q4 us-gaap Other Assets Current
OtherAssetsCurrent
8903000 usd
CY2024Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
85172000 usd
CY2023Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
43976000 usd
CY2024Q1 us-gaap Income Taxes Receivable Noncurrent
IncomeTaxesReceivableNoncurrent
79251000 usd
CY2023Q4 us-gaap Income Taxes Receivable Noncurrent
IncomeTaxesReceivableNoncurrent
76740000 usd
CY2024Q1 us-gaap Other Long Term Investments
OtherLongTermInvestments
33481000 usd
CY2023Q4 us-gaap Other Long Term Investments
OtherLongTermInvestments
31895000 usd
CY2024Q1 us-gaap Goodwill
Goodwill
22421000 usd
CY2023Q4 us-gaap Goodwill
Goodwill
22421000 usd
CY2024Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
17328000 usd
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
15746000 usd
CY2024Q1 us-gaap Other Assets Miscellaneous Noncurrent
OtherAssetsMiscellaneousNoncurrent
3579000 usd
CY2023Q4 us-gaap Other Assets Miscellaneous Noncurrent
OtherAssetsMiscellaneousNoncurrent
2854000 usd
CY2024Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
156060000 usd
CY2023Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
149656000 usd
CY2024Q1 idcc Customer Deposit Liability Current
CustomerDepositLiabilityCurrent
76100000 usd
CY2023Q4 idcc Customer Deposit Liability Current
CustomerDepositLiabilityCurrent
76100000 usd
CY2024Q1 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
16541000 usd
CY2023Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
10338000 usd
CY2024Q1 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
29525000 usd
CY2023Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
11604000 usd
CY2024Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
122166000 usd
CY2023Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
98042000 usd
CY2024Q1 us-gaap Deferred Compensation Liability Classified Noncurrent
DeferredCompensationLiabilityClassifiedNoncurrent
18967000 usd
CY2023Q4 us-gaap Deferred Compensation Liability Classified Noncurrent
DeferredCompensationLiabilityClassifiedNoncurrent
18413000 usd
CY2024Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
18547000 usd
CY2023Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
17385000 usd
CY2024Q1 us-gaap Other Sundry Liabilities Noncurrent
OtherSundryLiabilitiesNoncurrent
19413000 usd
CY2023Q4 us-gaap Other Sundry Liabilities Noncurrent
OtherSundryLiabilitiesNoncurrent
19454000 usd
CY2024Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
56927000 usd
CY2023Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
55252000 usd
CY2022Q2 us-gaap Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
5900000 shares
CY2019Q2 us-gaap Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
4900000 shares
CY2019Q2 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
109.43
CY2024Q1 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
109.43
CY2024Q1 idcc Payment To Cppib
PaymentToCPPIB
1600000 usd
CY2023Q1 us-gaap Litigation Settlement Amount Awarded From Other Party
LitigationSettlementAmountAwardedFromOtherParty
138700000 usd
CY2023Q2 idcc Litigation Settlement Attorney Fees
LitigationSettlementAttorneyFees
46200000 usd
CY2023Q2 us-gaap Litigation Settlement Amount Awarded From Other Party
LitigationSettlementAmountAwardedFromOtherParty
184900000 usd
CY2024Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.192
CY2023Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.140
CY2023Q1 idcc Effective Income Tax Rate Reconciliation Excluding Valuation Allowance Percent
EffectiveIncomeTaxRateReconciliationExcludingValuationAllowancePercent
0.138
CY2024Q1 idcc Discrete Tax Expense Benefit
DiscreteTaxExpenseBenefit
-1700000 usd
CY2023Q1 idcc Discrete Tax Expense Benefit
DiscreteTaxExpenseBenefit
-1000000 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
81652000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
105259000 usd
CY2024Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
25510000 shares
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
28780000 shares
CY2024Q1 idcc Incremental Common Shares Attributable To Dilutive Effect Of Stock Options Rs Us And Warrants
IncrementalCommonSharesAttributableToDilutiveEffectOfStockOptionsRSUsAndWarrants
889000 shares
CY2023Q1 idcc Incremental Common Shares Attributable To Dilutive Effect Of Stock Options Rs Us And Warrants
IncrementalCommonSharesAttributableToDilutiveEffectOfStockOptionsRSUsAndWarrants
592000 shares
CY2024Q1 idcc Incremental Common Shares Attributable To Dilutive Effect Of Convertible Securities
IncrementalCommonSharesAttributableToDilutiveEffectOfConvertibleSecurities
1942000 shares
CY2023Q1 idcc Incremental Common Shares Attributable To Dilutive Effect Of Convertible Securities
IncrementalCommonSharesAttributableToDilutiveEffectOfConvertibleSecurities
0 shares
CY2024Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
28341000 shares
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
29372000 shares
CY2024Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
3.20
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
3.66
CY2024Q1 idcc Dilutive Stock Options Rs Us And Warrants Effect On Basic Earnings Per Share Per Share
DilutiveStockOptionsRSUsAndWarrantsEffectOnBasicEarningsPerSharePerShare
0.10
CY2023Q1 idcc Dilutive Stock Options Rs Us And Warrants Effect On Basic Earnings Per Share Per Share
DilutiveStockOptionsRSUsAndWarrantsEffectOnBasicEarningsPerSharePerShare
0.08
CY2024Q1 idcc Dilutive Convertible Securities Effect On Basic Earnings Per Share Per Share
DilutiveConvertibleSecuritiesEffectOnBasicEarningsPerSharePerShare
0.22
CY2023Q1 idcc Dilutive Convertible Securities Effect On Basic Earnings Per Share Per Share
DilutiveConvertibleSecuritiesEffectOnBasicEarningsPerSharePerShare
0
CY2024Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
2.88
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
3.58
CY2024Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
7488000 shares
CY2023Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
7908000 shares
CY2024Q1 us-gaap Interest And Other Income
InterestAndOtherIncome
11778000 usd
CY2023Q1 us-gaap Interest And Other Income
InterestAndOtherIncome
11680000 usd
CY2024Q1 idcc Other Income Expense
OtherIncomeExpense
-2531000 usd
CY2023Q1 idcc Other Income Expense
OtherIncomeExpense
1511000 usd
CY2024Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
9247000 usd
CY2023Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
13191000 usd
CY2024Q1 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-2400000 usd
CY2023Q1 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
700000 usd
CY2024Q1 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2024Q1 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2024Q1 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false
CY2024Q1 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false

Files In Submission

Name View Source Status
0001405495-24-000072-index-headers.html Edgar Link pending
0001405495-24-000072-index.html Edgar Link pending
0001405495-24-000072.txt Edgar Link pending
0001405495-24-000072-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
idcc-20240331.htm Edgar Link pending
idcc-20240331.xsd Edgar Link pending
idcc-q133124ex311.htm Edgar Link pending
idcc-q133124ex321.htm Edgar Link pending
idcc-q133124ex322.htm Edgar Link pending
idccq133124ex312.htm Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
idcc-20240331_def.xml Edgar Link unprocessable
idcc-20240331_lab.xml Edgar Link unprocessable
idcc-20240331_pre.xml Edgar Link unprocessable
idcc-20240331_htm.xml Edgar Link completed
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
idcc-20240331_cal.xml Edgar Link unprocessable